Skip to content

Guide

AI's Value in Society

Look at the evidence for useful work, wider access, and scientific discovery, alongside the limits.

· 6 min read

AI can matter at a scale beyond a faster email. It can help people access information, help researchers investigate biology, and improve some forecasting and medical workflows. Each case needs its own evidence. Success in one field does not make a chatbot reliable in another.

AI is a broad family of methods for learning patterns and making predictions or generating outputs. Generative AI produces material such as text or images. The protein and flood systems below are specialized AI systems. Their results are not evidence that an everyday assistant can do scientific or emergency work safely.

Sources checked October 29, 2026. The cases distinguish measured outcomes, available capabilities, and possible future benefits.

Describing a picture someone cannot see

A photograph in a group chat may carry information that its caption leaves out. An image-description tool can describe the scene and respond to follow-up questions, giving a blind or low-vision reader another way to explore it.

Be My Eyes documents this capability in its Be My AI service, including screen-reader support and a route to a human volunteer. This is a deployed feature described by its provider, not an independent estimate of how much it improves everyone's life.

Descriptions can be wrong or incomplete. The provider explicitly warns against using them for medicines, dosages, and safety issues, and against sharing sensitive personal or financial information. It also explains how photos and chats are processed. Access has practical conditions: a supported device, connectivity, and permission to share the image.

The wider value is another route to information and everyday participation. It works best alongside accessible source material and human support. It does not excuse publishing an inaccessible document and leaving readers to repair it with AI.

Giving researchers a starting point for protein science

Proteins fold into shapes that affect what they do. Finding those shapes experimentally can be difficult. A useful prediction gives a researcher a hypothesis to investigate.

The AlphaFold Protein Structure Database, maintained by EMBL-EBI with Google DeepMind, openly provides hundreds of millions of predicted structures. Its collections support research into subjects including antimicrobial resistance and neglected tropical diseases. Making predictions available to many laboratories is a concrete scientific resource.

A predicted structure is not an approved medicine, a completed experiment, or proof of a cure. Researchers still need to assess confidence and test biological claims. The database itself links to limitations and experimental evidence.

This is one reason AI could be historically consequential: a specialized system can change the starting point for an entire field. Whether that produces affordable treatments depends on years of research and on institutions, funding, manufacturing, and access.

Extending the reach of flood forecasts

Some river basins have little local measurement data. That makes reliable forecasting harder, especially where early information could help communities prepare.

A 2024 Nature paper evaluated an AI river-flood forecasting system in watersheds without local gauges. At up to 5 days' lead time, its reliability was similar to or better than a comparison global system's forecasts made with no lead time. The authors reported incorporating it into an operational public early-warning system.

This result concerns river flooding and a particular evaluation. It does not establish that the model predicts every extreme event, or that better forecasts alone save a known number of lives. An alert must reach people who can understand it and have somewhere safe to go.

The public value comes from the full chain: forecast, trusted warning, local knowledge, and a workable response. Follow official local warnings rather than asking a general assistant whether a situation is safe.

Helping clinicians examine mammograms

A specialist system can highlight suspicious areas in a medical image or help organize a clinician's workload. That is a different setting from uploading symptoms to a chatbot.

The MASAI randomized trial, reported in The Lancet Digital Health in 2025, compared AI-supported mammography screening with standard double reading in Sweden. The system supported triage and radiologist reading. In this analysis, cancer detection was 6.4 per 1,000 screened participants with AI support versus 5.0 with standard screening, while the number of screen readings fell 44.2%. False-positive rates did not differ significantly.

It provides evidence for assessing a defined screening workflow. This screening analysis does not establish that every medical AI improves health, or that detecting more cancers necessarily improves survival. Benefit to patients, missed cases, unnecessary follow-up, and performance across patient groups all matter.

Evaluated tools may help care teams use scarce attention more effectively. Qualified clinicians and health systems remain responsible for deciding where a system belongs and monitoring what happens after adoption.

Making some professional tasks easier to do well

Useful work often involves turning rough information into something another person can use. An assistant can suggest a draft while the person remains responsible for the result.

In Generative AI at Work, published in 2025, researchers studied a staggered assistant rollout using data from 5,172 customer support agents at one firm. Resolved issues per hour rose 15% on average. Less experienced workers benefited more; the most skilled agents saw small quality declines.

A separate 2023 randomized writing study of 453 professionals found faster completion and higher evaluator-rated quality on assigned writing tasks. Neither study establishes that all work becomes easier or that workers receive the financial gains.

Task improvements also do not translate automatically into economy-wide wage or employment gains. A Danish study revised in 2026 found no average earnings or recorded-hours effects larger than 2% within its study horizon, despite task reorganization. That working paper describes one setting and period, not the eventual impact everywhere.

The useful question for a team is whether the completed, checked work improves. Counting how many drafts a tool produces skips the part where someone has to read them.

Supporting learning without skipping the learning

A patient explanation, another example, or a practice question can be valuable to someone who has no tutor available. A conversational interface makes asking a follow-up question easy. Whether it improves learning depends on how it is used and evaluated.

A 2025 randomized study of high-school mathematics found that unrestricted AI assistance helped practice performance but harmed later performance without the tool. A version designed to protect learning largely mitigated that harm in the study. Getting through today's worksheet and learning the method are different achievements.

A safer personal experiment is to try first, ask for hints, explain the answer back, and test yourself without assistance. Teachers still need evidence about the actual tool, subject, and students before relying on it.

The prospect of more accessible help is worth exploring. It should be judged by what people learn and retain, including those whose language, disability, or circumstances a tool handles poorly.

Benefits are possible; fair outcomes need decisions

These cases show why AI deserves serious attention. They do not add up to a single score proving that all uses are good for society. Faster research, better access, and useful work can coexist with privacy violations, discrimination, insecure jobs, misinformation, and environmental costs.

The ILO's task-based research finds uneven job exposure. The IEA's energy analysis describes growing data-center electricity demand and infrastructure pressures. NIST's generative AI risk profile sets out risks that a useful demonstration cannot rule out.

When judging a proposed use, ask:

  • What changed for people, and how was it measured?
  • Who benefits, who pays, and who has no meaningful choice?
  • Can affected people understand and challenge an error?
  • Is a simpler method as good or better?
  • What would make the organization stop using the system?

The technology's potential is substantial. How much becomes lasting public value depends on evidence, access, oversight, and choices about whose interests it serves.

Explore practical examples, open common questions and concerns, or read how to assess AI claims.

Sources

All guides